Cargando…
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
BACKGROUND: Fibroblast growth factor 21 (FGF21) has demonstrated beneficial effects on lipid and carbohydrate metabolism. In cross‐sectional studies, an association of raised circulating FGF21 levels with coronary heart disease (CHD) was found in some but not all studies. Here we investigated prospe...
Autores principales: | Lee, Chi Ho, Woo, Yu Cho, Chow, Wing Sun, Cheung, Chloe Yu Yan, Fong, Carol Ho Yi, Yuen, Michele Mae Ann, Xu, Aimin, Tse, Hung Fat, Lam, Karen Siu Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669163/ https://www.ncbi.nlm.nih.gov/pubmed/28588089 http://dx.doi.org/10.1161/JAHA.116.005344 |
Ejemplares similares
-
Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective Study
por: Chow, Wing Sun, et al.
Publicado: (2013) -
Identification of ANXA2 as a Potential Susceptibility Gene for Diabetic Retinopathy in a Genome-Wide Association Analysis in Chinese Patients With Type 2 Diabetes Mellitus
por: Cheung, Chloe Y Y, et al.
Publicado: (2021) -
PSUN156 Circulating thrombospondin-2 level as a novel biomarker of heart failure in type 2 diabetes
por: Lee, Chi-Ho, et al.
Publicado: (2022) -
Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus
por: Liu, Ju-Hua, et al.
Publicado: (2016) -
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
por: Wong, Yuen-Kwun, et al.
Publicado: (2019)